MedAvail Holdings, Inc.

MDVL · NASDAQ
Analyze with AI
6/30/2023
3/31/2023
12/31/2022
9/30/2022
Revenue$405$620$11,350$11,461
% Growth-34.7%-94.5%-1%
Cost of Goods Sold$227$363$11,476$10,169
Gross Profit$178$257-$126$1,292
% Margin44%41.5%-1.1%11.3%
R&D Expenses$145$176$163$178
G&A Expenses$4,422$4,960$4,770$10,942
SG&A Expenses$4,432$5,092$6,518$11,108
Sales & Mktg Exp.$10$132$1,748$166
Other Operating Expenses$0$0$3,937$1,497
Operating Expenses$4,632$5,268$10,618$12,783
Operating Income-$4,454-$5,011-$10,744-$11,491
% Margin-1,099.8%-808.2%-94.7%-100.3%
Other Income/Exp. Net-$1,042-$7,547-$326-$315
Pre-Tax Income-$5,496-$12,558-$11,070-$11,806
Tax Expense$295$4,941-$1$315
Net Income-$5,791-$17,499-$11,069-$12,121
% Margin-1,429.9%-2,822.4%-97.5%-105.8%
EPS-3.22-10.9-6.9-7.7
% Growth70.5%-58%10.4%
EPS Diluted-3.22-10.9-6.9-7.57
Weighted Avg Shares Out1,7981,6051,6051,574
Weighted Avg Shares Out Dil1,7981,6051,6051,601
Supplemental Information
Interest Income$146$1$1$315
Interest Expense$146$169$327$315
Depreciation & Amortization$431$1$1$1,780
EBITDA-$4,919-$12,388-$10,742-$9,711
% Margin-1,214.6%-1,998.1%-94.6%-84.7%